ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
JackBNimble
|
94 |
18K |
9 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
94
|
18K
|
9
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Trading Halt
|
|
JackBNimble
|
35 |
8.3K |
1 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
35
|
8.3K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Trading Halt
|
|
JackBNimble
|
35 |
8.3K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
35
|
8.3K
|
6
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Trading Halt
|
|
JackBNimble
|
35 |
8.3K |
8 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
35
|
8.3K
|
8
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Trading Halt
|
|
JackBNimble
|
35 |
8.3K |
3 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
35
|
8.3K
|
3
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Genetic Signatures Announces $30 Million Capital Raising
|
|
JackBNimble
|
6 |
1.1K |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
6
|
1.1K
|
0
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.8K |
1.2M |
1 |
03/06/24 |
03/06/24 |
IPOs
|
1.8K
|
1.2M
|
1
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.8K |
1.2M |
2 |
03/06/24 |
03/06/24 |
IPOs
|
1.8K
|
1.2M
|
2
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
JackBNimble
|
24 |
5.8K |
3 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
24
|
5.8K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
JackBNimble
|
24 |
5.8K |
1 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
24
|
5.8K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
JackBNimble
|
24 |
5.8K |
2 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
5.8K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
JackBNimble
|
24 |
5.8K |
0 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
5.8K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
JackBNimble
|
24 |
5.8K |
0 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
5.8K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
JackBNimble
|
85 |
20K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
20K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
478 |
109K |
14 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
478
|
109K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
478 |
109K |
20 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
478
|
109K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
478 |
109K |
7 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
478
|
109K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
478 |
109K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
478
|
109K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
478 |
109K |
9 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
478
|
109K
|
9
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.8K |
1.2M |
5 |
30/05/24 |
30/05/24 |
IPOs
|
1.8K
|
1.2M
|
5
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
2 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
109
|
29K
|
2
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
0 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
109
|
29K
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
109
|
29K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
109
|
29K
|
1
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.8K |
1.2M |
0 |
24/05/24 |
24/05/24 |
IPOs
|
1.8K
|
1.2M
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
109
|
29K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
109
|
29K
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
109
|
29K
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
109
|
29K
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
109
|
29K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
478 |
109K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
478
|
109K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
478 |
109K |
8 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
478
|
109K
|
8
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
2 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
109
|
29K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
478 |
109K |
10 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
478
|
109K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
478 |
109K |
17 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
478
|
109K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
JackBNimble
|
478 |
109K |
6 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
478
|
109K
|
6
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
4 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
109
|
29K
|
4
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
109
|
29K
|
4
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
109
|
29K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
1 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
109
|
29K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
JackBNimble
|
86 |
20K |
12 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
86
|
20K
|
12
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
2 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
109
|
29K
|
2
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Final Patients dosed in SPONTAN pivotal study
|
|
JackBNimble
|
109 |
29K |
5 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
109
|
29K
|
5
|
|
ASX - By Stock
|
LTP |
Re:
The Trials
|
|
JackBNimble
|
27 |
11K |
5 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
27
|
11K
|
5
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.8K |
1.2M |
2 |
04/05/24 |
04/05/24 |
IPOs
|
1.8K
|
1.2M
|
2
|
|
ASX - By Stock
|
GHY |
Re:
SUPERTHREAD - conferences, events, and media
|
|
JackBNimble
|
20 |
9.6K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
20
|
9.6K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
The Trials
|
|
JackBNimble
|
27 |
11K |
2 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
27
|
11K
|
2
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.8K |
1.2M |
2 |
30/04/24 |
30/04/24 |
IPOs
|
1.8K
|
1.2M
|
2
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.8K |
1.2M |
2 |
22/04/24 |
22/04/24 |
IPOs
|
1.8K
|
1.2M
|
2
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
JackBNimble
|
1.8K |
1.2M |
3 |
22/04/24 |
22/04/24 |
IPOs
|
1.8K
|
1.2M
|
3
|
|